tirzepatide studies Dual Agonist (GLP-1/GIP) Tirzepatide, a New Era of

PMID: 33403891

As GLP1 medications reduce body weight and inflammation, some patients may experience a corresponding improvement in mood

A score of 0 indicates a low-risk patient who, alongside the clinicians judgement, may be safely discharged and an outpatient endoscopy can be arranged as their follow-up

This type of strategic placement can rebuild structural support and create a more rested appearance without making the face look overfilled

This makes large meals unrealistic

Weight loss from Ozempic reduces neck circumference and pharyngeal fat deposits, which can decrease upper airway collapsibility during sleep